Stay updated with breaking news from Lymphoma Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as foundation for various investigational CAR-T therapies Early data from first-in-human dose-escalation
/PRNewswire/ -- Novartis today announced the introduction of T-Charge™, the company's next-generation CAR-T platform that will serve as the foundation for...
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021